Condition

Maintenance Therapy clinical trials and research

• 7Clinical trials
• 1Country

Newest Maintenance Therapy clinical trials

All recruiting trials (7)

• Menin inhibitor maintenance after allogeneic stem cell transplant

  This project will try menin inhibitor maintenance to see if it helps people with acute leukemia after allogeneic stem cell transplant who have KMT2A or related gene changes.

  Recruiting The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT07559695

• Autologous peptide vaccine as maintenance therapy for AML

  This study tests whether a personalized vaccine made from a patient's own peptides can help prevent relapse in adults with acute myeloid leukemia who are in remission and receiving consolidation/maintenance chemotherapy.

  Recruiting Phase 1 Fujian Medical University Union Hospital · Fuzhou, Fujian · NCT07551037

• MRD‑guided maintenance after transplant: gilteritinib versus sorafenib

  This trial tests whether taking gilteritinib or sorafenib after an allogeneic stem cell transplant helps people aged 14–70 with FLT3‑ITD–positive AML who were MRD‑positive before transplant.

  Recruiting at 2 sites Phase 3 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu and 1 other locations · NCT07463651

• BN104 maintenance after allogeneic stem cell transplant for acute leukemia

  This trial tests whether taking the oral menin inhibitor BN104 can reduce relapse in people with acute leukemia who have specific genetic changes and are 1–6 months after an allogeneic stem cell transplant.

  Recruiting Phase 2 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT07101497

• Using Zanubrutinib to maintain remission in patients with Mantle Cell Lymphoma

  This study is testing if Zanubrutinib can help people with mantle cell lymphoma stay in remission after their initial treatment.

  Recruiting at 2 sites Phase 2 Fudan University · Shanghai, Shanghai Municipality and 1 other locations · NCT06341556

• Combining Toripalimab with Capecitabine for High-Risk Nasopharyngeal Carcinoma

  This study is testing if combining toripalimab with capecitabine can help high-risk nasopharyngeal cancer patients avoid cancer coming back after their initial treatment.

  Recruiting at 2 sites Phase 3 Jiangxi Provincial Cancer Hospital · Ganzhou, Jiangxi and 2 other locations · NCT06277050

• Comparing Telitacicept with Azathioprine for ANCA-associated Vasculitis Maintenance

  This study is testing if adding a new drug called Telitacicept to the standard treatment can help people with ANCA-associated vasculitis stay in remission longer.

  Recruiting Phase 4 Chinese SLE Treatment And Research Group · Beijing, Beijing Municipality · NCT05965284

Related topics

Quick answers

How many Maintenance Therapy clinical trials are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 2, Phase 2: 2, Phase 1: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →